Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Landgren, Ola"'
Autor:
Anderson, Kenneth, Auclair, Daniel, Adam, Stacey J., Agarwal, Amit, Anderson, Melissa, Avet-Loiseau, Hervé, Bustoros, Mark, Chapman, Jessica, Connors, Dana E., Dash, Ajeeta B., Di Bacco, Alessandra, Du, Ling, Facon, Thierry, Flores-Montero, Juan, Gay, Francesca, Ghobrial, Irene M., Gormley, Nicole J., Gupta, Ira, Higley, Howard, Hillengass, Jens, Kanapuru, Bindu, Kazandjian, Dickran, Kelloff, Gary J., Kirsch, Ilan R., Kremer, Brandon, Landgren, Ola, Lightbody, Elizabeth, Lomas, Oliver C., Lonial, Sagar, Mateos, Maria Victoria, Montes de Oca, Rocío, Mukundan, Lata, Munshi, Nikhil, O’Donnell, Elizabeth K., Orfao, Alberto, Paiva, Bruno, Patel, Reshma, Pugh, Trevor J., Ramasamy, Karthik, Ray, Jill, Roshal, Mikhail, Ross, J. A., Sigman, Caroline C., Thoren, Katie L., Trudel, Suzanne, Ulaner, Gary, Valente, Nancy, Weiss, Brendan M., Zamagni, Elena, Kumar, S.
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
The development of novel agents has transformed the treatment paradigm for multiple myeloma, with minimal residual disease (MRD) negativity now achievable across the entire disease spectrum. Bone marrow–based technologies to assess MRD, including a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::75cc94bb4ba2dc3504d95369b45d0d30
http://hdl.handle.net/10261/261808
http://hdl.handle.net/10261/261808
Autor:
McShane, Charlene M., Murray, Liam J., Landgren, Ola, O'Rorke, Michael A., Korde, Neha, Kunzmann, Andrew T., Ismail, Mohammad Roshidi, Anderson, Lesley A.
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention; Feb2014, Vol. 23 Issue 2, p332-342, 11p
Autor:
Quinlan, Scott C., Morton, Lindsay M., Pfeiffer, Ruth M., Anderson, Lesley A., Landgren, Ola, Warren, Joan L., Engels, Eric A.
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention; May2010, Vol. 19 Issue 5, p1229-1237, 9p, 3 Charts, 1 Graph
Autor:
Hofmann, Jonathan N.1 hofmannjn@mail.nih.gov, Birmann, Brenda M.2, Teras, Lauren R.3, Pfeiffer, Ruth M.1, Ye Wang4, Albanes, Demetrius1, Baris, Dalsu1, Colditz, Graham A.5,6, De Roos, Anneclaire J.7, Giles, Graham G.8, Hosgood, H. Dean9, Qing Lan1, Landgren, Ola10, Liao, Linda M.1, Rothman, Nathaniel1, Weinstein, Stephanie J.1, Pollak, Michael N.4, Neuhouser, Marian L.11, Purdue, Mark P.1
Publikováno v:
Cancer Research. 4/1/2016, Vol. 76 Issue 7, p1935-1941. 7p.
Autor:
Simmons, John Kyle1, Mock, Beverly A.1, Michalowski, Aleksandra1, Patel, Jyoti1, Wei, Bih-Rong1, Simpson, R. Mark1, Kuehl, W. Michael1, Zhang, Shuling1, Ke Zhang1, Landgren, Ola1
Publikováno v:
Cancer Research. Jul2012 Meeting Abstracts, Vol. 72 Issue 13a, p26-26. 3/4p.
Autor:
Kowalski A; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Lykon J; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Coffey DG; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Kaddoura M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Hoffman JE; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Kazandjian D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2024 Mar 01; Vol. 5 (2), pp. 90-94.
Autor:
Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Kazandjian D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2023 Sep 01; Vol. 4 (5), pp. 346-348.
Autor:
Maura F; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Ziccheddu B; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Xiang JZ; Weill Cornell Medical College, New York, New York.; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Bhinder B; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Rosiene J; Weill Cornell Medical College, New York, New York., Abascal F; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, United Kingdom., Maclachlan KH; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Eng KW; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Uppal M; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York., He F; Weill Cornell Medical College, New York, New York., Zhang W; Weill Cornell Medical College, New York, New York., Gao Q; Memorial Sloan Kettering Cancer Center, New York, New York., Yellapantula VD; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles, Los Angeles, California., Trujillo-Alonso V; Weill Cornell Medical College, New York, New York., Park SI; Department of Pathology, Children's Hospital of Atlanta, Atlanta, Georgia., Oberley MJ; Caris Life Sciences, Phoenix, Arizona., Ruckdeschel E; Department of Pathology, Upstate Medical University, Syracuse, New York., Lim MS; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Philadelphia., Wertheim GB; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Philadelphia., Barth MJ; Department of Pediatrics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Horton TM; Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Derkach A; Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., Kovach AE; Children's Hospital of Los Angeles, Los Angeles, California., Forlenza CJ; Memorial Sloan Kettering Cancer Center, New York, New York., Zhang Y; Memorial Sloan Kettering Cancer Center, New York, New York., Landgren O; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Moskowitz CH; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Cesarman E; Weill Cornell Medical College, New York, New York., Imielinski M; Weill Cornell Medical College, New York, New York.; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Elemento O; Weill Cornell Medical College, New York, New York.; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Roshal M; Memorial Sloan Kettering Cancer Center, New York, New York., Giulino-Roth L; Weill Cornell Medical College, New York, New York.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2023 May 01; Vol. 4 (3), pp. 208-227.
Autor:
Hultcrantz M, Richter J, Rosenbaum CA, Patel D, Smith EL, Korde N, Lu SX, Mailankody S, Shah UA, Lesokhin AM, Hassoun H, Tan C, Maura F, Derkach A, Diamond B, Rossi A, Pearse R, Madduri D, Chari A, Kaminetzky D, Braunstein MJ, Gordillo C, Reshef R, Taur Y, Davies FE, Jagannath S, Niesvizky R, Lentzsch S, Morgan GJ, Landgren O
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2020 Nov 04; Vol. 1 (3), pp. 290. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).
Autor:
Rustad EH; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Yellapantula VD; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Glodzik D; Epidemiology & Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Maclachlan KH; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Diamond B; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Boyle EM; NYU Perlmutter Cancer Center, New York, New York., Ashby C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Blaney P; NYU Perlmutter Cancer Center, New York, New York., Gundem G; Epidemiology & Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Leongamornlert D; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Angelopoulos N; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.; School of Computer Science and Electronic Engineering, University of Essex, Colchester, United Kingdom., Agnelli L; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Auclair D; Multiple Myeloma Research Foundation (MMRF), Norwalk, Connecticut., Zhang Y; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Dogan A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Bolli N; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Papaemmanuil E; Epidemiology & Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Anderson KC; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Moreau P; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France., Avet-Loiseau H; IUC-Oncopole, and CRCT INSERM U1037, Toulouse, France., Munshi NC; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Veterans Administration Boston Healthcare System, West Roxbury, Massachusetts., Keats JJ; Translational Genomics Research Institute (TGen), Phoenix, Arizona., Campbell PJ; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Morgan GJ; NYU Perlmutter Cancer Center, New York, New York., Landgren O; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Maura F; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. mauraf@mskcc.org.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2020 Nov; Vol. 1 (3), pp. 258-273. Date of Electronic Publication: 2020 Sep 15.